QTTB Q3 2023 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$73M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+131.8% YoY

Gross Profit

$2M93.3% margin

Operating Income

-$8M-419.5% margin

Net Income

-$14M-754.8% margin

EPS (Diluted)

$-10.25

QoQ Revenue Growth

-42.0%

Cash Flow

Operating Cash Flow

$16M

Free Cash Flow

$16M

Stock-Based Comp.

$301,000

Balance Sheet

Total Assets

$54M

Total Liabilities

$210M

Stockholders' Equity

-$156M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$802,000	+131.8%
Gross Profit	$2M	$167,000	+938.9%
Operating Income	-$8M	-$33M	+76.3%
Net Income	-$14M	-$34M	+58.4%